Dietary folate and related micronutrients, folate-metabolising genes, and ovarian cancer survival
Suzanne C. Dixon‐Suen(Cancer Council Victoria), Christina M. Nagle(The University of Queensland), G. Gard(Royal North Shore Hospital), Alex J. Crandon(St Vincent’s Private Hospital Brisbane), Melinda M. Protani(The University of Sydney), Torukiri I Ibiebele(QIMR Berghofer Medical Research Institute), Jonathan Beesley(QIMR Berghofer Medical Research Institute), Penelope M. Webb(QIMR Berghofer Medical Research Institute), Robert Rome(Royal Women's Hospital), Anna DeFazio(The University of Sydney)
Cited by 33
Related Papers
Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
|Clinical Cancer Research|2008|1.5k
<i>BRCA</i> Mutation Frequency and Patterns of Treatment Response in <i>BRCA</i> Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
|Journal of Clinical Oncology|2012|1.2k
Driver mutations in <i>TP53</i> are ubiquitous in high grade serous carcinoma of the ovary
|The Journal of Pathology|2010|836
Type I and II Endometrial Cancers: Have They Different Risk Factors?
|Journal of Clinical Oncology|2013|833
Mutation of <i>FOXL2</i> in Granulosa-Cell Tumors of the Ovary
|New England Journal of Medicine|2009|775